elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q40333043-CD6DB03E-8B0C-4823-84AE-452F68D0A478
Q40333043-CD6DB03E-8B0C-4823-84AE-452F68D0A478
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40333043-CD6DB03E-8B0C-4823-84AE-452F68D0A478
Phase I trial of weekly and twice-weekly bortezomib with rituximab, cyclophosphamide, and prednisone in relapsed or refractory non-Hodgkin lymphoma.
P50
Q40333043-CD6DB03E-8B0C-4823-84AE-452F68D0A478
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40333043-CD6DB03E-8B0C-4823-84AE-452F68D0A478
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
709aee645d08f0edd8744f8ebdd52df7ce2ccdc8
P1545
5
http://www.w3.org/2001/XMLSchema#string
P50
Ariela Noy